NCT06953180 Epigenetics and NCD Prevention in Kazakhstan: Personalized Approaches and Biological Age Prediction
| NCT ID | NCT06953180 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Asfendiyarov Kazakh National Medical University |
| Condition | Cardiovascular Diseases (CVD) |
| Study Type | OBSERVATIONAL |
| Enrollment | 6,720 participants |
| Start Date | 2025-03-03 |
| Primary Completion | 2026-01-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 6,720 participants in total. It began in 2025-03-03 with a primary completion date of 2026-01-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to enhance personalized and preventive care for non-communicable diseases (NCDs) in Kazakhstan by examining epigenetic factors, predicting biological age and reproductive function using machine learning, and developing health improvement recommendations.
Eligibility Criteria
Inclusion Criteria: * Adults aged 18 to 69 years. * Residents of 17 regions of Kazakhstan. * Willingness to participate and provide informed consent. Exclusion Criteria: * Age less than 18 years old or over 69 years old. * Failure to provide informed consent or incomplete participation in data collection procedures.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06953180 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 69 Years, studying Cardiovascular Diseases (CVD). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06953180 currently recruiting?
Yes, NCT06953180 is actively recruiting participants. Contact the research team at fakhradiyev.i@kaznmu.kz for enrollment information.
Where is the NCT06953180 trial being conducted?
This trial is being conducted at Almaty, Kazakhstan.
Who is sponsoring the NCT06953180 clinical trial?
NCT06953180 is sponsored by Asfendiyarov Kazakh National Medical University. The trial plans to enroll 6,720 participants.